Droxidopa Capsule
Product Images NDC 68180-987

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Droxidopa (NDC 68180-987). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (73d75f21 7817 4a1a 9016 168526fa1c71 01)

Chemical structure diagram of droxidopa, showing its molecular formula with a benzene ring and attached functional groups consistent with droxidopa's known structure.*

FDA Label Image

Image-02 (73d75f21 7817 4a1a 9016 168526fa1c71 02)

A line graph depicting the mean change in dizziness over eight weeks in a double-blind treatment phase comparing Droxidopa and placebo. The x-axis represents weeks from baseline to week 8, while the y-axis shows mean change in dizziness. Droxidopa shows a greater reduction in dizziness than placebo, especially at week 1 with a statistically significant difference (p<0.05). Error bars indicate variability at each time point.*

FDA Label Image

Image-03 (73d75f21 7817 4a1a 9016 168526fa1c71 03)

Bar chart comparing percent of subjects showing improvement in OHSA Question 1 responses between Droxidopa and Placebo groups. The x-axis ranges from -8 (worse) to 8 (better) improvement scores, and the y-axis shows percent of subjects, with separate bars for Placebo (white) and Droxidopa (black).*

FDA Label Image

Image (73d75f21 7817 4a1a 9016 168526fa1c71 04)

Droxdopa Capsules 100 mg oral capsules label displaying the product name, strength, quantity of 90 capsules, and manufacturer details. The label includes storage instructions and warnings, and shows it is a prescription drug by Lupin Pharmaceuticals, Inc., made by Lupin Limited in India.*

FDA Label Image

Image (73d75f21 7817 4a1a 9016 168526fa1c71 05)

Label for Droxidopa 200 mg capsules, an oral prescription drug by Lupin Pharmaceuticals, Inc. The label states 90 capsules per container and includes storage instructions and warnings. It mentions the product is manufactured by Lupin Limited in India and is labeled with NDC 68180-988-09.*

FDA Label Image

Image (73d75f21 7817 4a1a 9016 168526fa1c71 06)

Packaging label for Droxidopa Capsules 300 mg, oral dosage form, manufactured by Lupin Pharmaceuticals, Inc. The label indicates a package size of 90 capsules and includes storage instructions, warnings, and manufacturing details. The label features a barcode and identifies the product as prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.